Literature DB >> 12208413

Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection.

Krishnamoorthy Vivekananthan1, Thomachan Kalapura, Mandeep Mehra, Carl Lavie, Richard Milani, Robert Scott, Myung Park.   

Abstract

Systolic and diastolic myocardial performance characteristics are altered during allograft rejection. Noninvasive diagnostic markers of allograft rejection have thus far not been found to be clinically useful and have not replaced routine endomyocardial biopsy as a method to detect rejection. We examined the clinical utility of the Index of Myocardial Performance (IMP), or the Tei index, a combined index of systolic and diastolic performance (derived as a composite ratio of isovolumetric contraction time and isovolumetric relaxation time to the ejection time), in evaluating and following cardiac allograft rejection. Twenty heart transplant recipients with moderate cellular rejection (International Society for Heart and Lung Transplantation [ISHLT] grade 3A) underwent echocardiographic assessment to derive the IMP at baseline (rejection free), during treatment of rejection, and after recovery from rejection (group I). A parallel group of 20 nonrejecters (ISHLT grade 1A) were also similarly examined to serve as controls (group II). In group I patients, there was a mean increase of IMP by 98% (p <0.0001) during the rejection episode compared with baseline. After treatment, IMP decreased to its baseline value. In the control group there was no significant change in IMP over time. An IMP increase of >/=20% from baseline had 90% sensitivity and 90% specificity in detecting high-grade cardiac allograft rejection. The change in IMP in patients with grade 3A cellular rejection was independent of both the ejection fraction at baseline and change in ejection fraction during the rejection episode. These results indicate that changes in IMP, a sensitive marker of early diastolic and systolic performance, accurately evaluate the development of, and recovery from, cardiac allograft rejection. IMP can provide a clinically useful noninvasive indicator to assess the impact of therapy for amelioration of allograft rejection.

Entities:  

Mesh:

Year:  2002        PMID: 12208413     DOI: 10.1016/s0002-9149(02)02525-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Myocardial performance index suggests optimal fluid loss during hemodialysis.

Authors:  Elektra S Papadopoulou; Savvas T Toumanidis; George Tsirpanlis; Chrisanthi O Trika; Garyfalia Kalatzopoulou; Spyridon D Moulopoulos
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

2.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

3.  Preventive cardiology and non-invasive cardiology research at the ochsner clinic foundation.

Authors:  Carl J Lavie; Richard V Milani; Yvonne Gilliland; J Alberto Bernal; Homeyar Dinshaw; Hector O Ventura
Journal:  Ochsner J       Date:  2006

4.  Noninvasive assessment of the right and left ventricular function in neonates with congenital diaphragmatic hernia with persistent pulmonary hypertension before and after surgical repair.

Authors:  Steffan Sernich; Noe Carrasquero; Carl J Lavie; Richard Chambers; Marie McGettigan
Journal:  Ochsner J       Date:  2006

5.  Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection.

Authors:  Andrew J Taylor; Gautam Vaddadi; Heinz Pfluger; Michelle Butler; Peter Bergin; Angeline Leet; Meroula Richardson; Joshi Cherayath; Leah Iles; David M Kaye
Journal:  Eur J Heart Fail       Date:  2010-01       Impact factor: 15.534

Review 6.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion.

Authors:  Feyzullah Besli; Cengiz Basar; Mesut Kecebas; Yasin Turker
Journal:  J Interv Card Electrophysiol       Date:  2015-01-16       Impact factor: 1.900

8.  Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation.

Authors:  Ryan S Dolan; Amir A Rahsepar; Julie Blaisdell; Kenichiro Suwa; Kambiz Ghafourian; Jane E Wilcox; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Allen S Anderson; Clyde W Yancy; Jeremy D Collins; James C Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2019-03-13

9.  Evaluation of myocardial performance index to predict mild rejection in cardiac transplantation.

Authors:  Savvas T Toumanidis; Electra S Papadopoulou; Nikolaos S Saridakis; Anna T Kalantaridou; Emmanuel V Agapitos; John N Nanas; Stamatios F Stamatelopoulos
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

Review 10.  Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review.

Authors:  Craig R Butler; Richard Thompson; Mark Haykowsky; Mustafa Toma; Ian Paterson
Journal:  J Cardiovasc Magn Reson       Date:  2009-03-12       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.